Life science venture capital firm Medical Excellence Capital has closed on its $145 million fund.
Medical Excellence Capital is the venture capital arm of private health advisory company Medical Excellence Group. Medical Excellence Capital will target investments in cell therapy, gene therapy, synthetic biology and regenerative medicine, according to the Medical Excellence Capital Aug. 23 news release.
"We are seeing exciting discoveries and technologies in multiple areas of healthcare," managing partner at Medical Excellence Capital Eric Heil said. "We believe that with this exclusive medical network, Medical Excellence Capital is well positioned to accelerate the development of these discoveries in critical unmet need areas where patients and doctors can realize significant improvements in patient outcomes."